{"id":"https://openalex.org/W2885460705","doi":"https://doi.org/10.1177/1078155218791333","title":"Single 6-mg dose of rasburicase: The experience in a large academic medical center","display_name":"Single 6-mg dose of rasburicase: The experience in a large academic medical center","publication_year":2018,"publication_date":"2018-08-15","ids":{"openalex":"https://openalex.org/W2885460705","doi":"https://doi.org/10.1177/1078155218791333","mag":"2885460705","pmid":"https://pubmed.ncbi.nlm.nih.gov/30111244"},"language":"en","primary_location":{"id":"doi:10.1177/1078155218791333","doi":"https://doi.org/10.1177/1078155218791333","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1078155218791333","pdf_url":null,"source":{"id":"https://openalex.org/S66425452","display_name":"Journal of Oncology Pharmacy Practice","issn_l":"1078-1552","issn":["1078-1552","1477-092X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Oncology Pharmacy Practice","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048925384","display_name":"Mary Nauffal","orcid":"https://orcid.org/0000-0002-4957-6954","observed_orcids":["https://orcid.org/0000-0002-4957-6954"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary Nauffal","raw_affiliation_strings":["Department of Pharmacy Services, Brigham and Women\u2019s Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Services, Brigham and Women\u2019s Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015287155","display_name":"Robert Allyn Redd","orcid":"https://orcid.org/0000-0002-1329-5288","observed_orcids":["https://orcid.org/0000-0002-1329-5288"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Redd","raw_affiliation_strings":["Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108770330","display_name":"Jian Ni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jian Ni","raw_affiliation_strings":["Department of Pharmacy Services, Brigham and Women\u2019s Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Services, Brigham and Women\u2019s Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071023119","display_name":"Richard Maury Stone","orcid":"https://orcid.org/0000-0002-7526-2633","observed_orcids":["https://orcid.org/0000-0002-7526-2633"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard M Stone","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082924494","display_name":"Daniel J. DeAngelo","orcid":"https://orcid.org/0000-0001-7865-2306","observed_orcids":["https://orcid.org/0000-0001-7865-2306"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel J DeAngelo","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031244084","display_name":"Anne McDonnell","orcid":"https://orcid.org/0000-0001-8426-5222","observed_orcids":["https://orcid.org/0000-0001-8426-5222"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Anne M McDonnell","raw_affiliation_strings":["Department of Pharmacy Services, Brigham and Women\u2019s Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Services, Brigham and Women\u2019s Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5031244084"],"corresponding_institution_ids":["https://openalex.org/I1283280774"],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":0.7534,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.72995819,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"25","issue":"6","first_page":"1349","last_page":"1356"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12845","display_name":"Methemoglobinemia and Tumor Lysis Syndrome","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12845","display_name":"Methemoglobinemia and Tumor Lysis Syndrome","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12117","display_name":"Muscle and Compartmental Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rasburicase","display_name":"rasburicase","score":0.8820000290870667},{"id":"https://openalex.org/keywords/tumor-lysis-syndrome","display_name":"tumor lysis syndrome","score":0.9869999885559082},{"id":"https://openalex.org/keywords/uric-acid","display_name":"uric acid","score":0.6740000247955322},{"id":"https://openalex.org/keywords/single-dose-administration","display_name":"single-dose administration","score":0.6579999923706055},{"id":"https://openalex.org/keywords/urate-oxidase","display_name":"uricase","score":0.8989999890327454},{"id":"https://openalex.org/keywords/hyperuricemia","display_name":"hyperuricemia","score":0.8059999942779541},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.6320000290870667},{"id":"https://openalex.org/keywords/risk-factors-for-treatment-failure","display_name":"risk factors for treatment failure","score":0.7519999742507935},{"id":"https://openalex.org/keywords/lactate-dehydrogenase","display_name":"lactate dehydrogenase","score":0.8659999966621399},{"id":"https://openalex.org/keywords/creatinine-clearance","display_name":"creatinine clearance","score":0.6629999876022339},{"id":"https://openalex.org/keywords/oncologic-emergencies","display_name":"oncologic emergencies","score":0.6460000276565552},{"id":"https://openalex.org/keywords/chemotherapy-side-effects","display_name":"chemotherapy side effects","score":0.47999998927116394},{"id":"https://openalex.org/keywords/acute-kidney-injury","display_name":"acute kidney injury","score":0.4690000116825104},{"id":"https://openalex.org/keywords/hypercalcemia","display_name":"hypercalcemia","score":0.5389999747276306},{"id":"https://openalex.org/keywords/hyperphosphatemia","display_name":"hyperphosphatemia","score":0.8939999938011169},{"id":"https://openalex.org/keywords/acidosis","display_name":"acidosis","score":0.4950000047683716}],"concepts":[{"id":"https://openalex.org/C2778939600","wikidata":"https://www.wikidata.org/wiki/Q3088229","display_name":"Rasburicase","level":4,"score":0.999008297920227},{"id":"https://openalex.org/C2779788671","wikidata":"https://www.wikidata.org/wiki/Q998803","display_name":"Tumor lysis syndrome","level":3,"score":0.963190495967865},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8149908781051636},{"id":"https://openalex.org/C2779881121","wikidata":"https://www.wikidata.org/wiki/Q105522","display_name":"Uric acid","level":2,"score":0.8084909915924072},{"id":"https://openalex.org/C2776943133","wikidata":"https://www.wikidata.org/wiki/Q18057009","display_name":"Urate oxidase","level":3,"score":0.6515562534332275},{"id":"https://openalex.org/C2779721657","wikidata":"https://www.wikidata.org/wiki/Q49970","display_name":"Hyperuricemia","level":3,"score":0.6311709880828857},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.5236934423446655},{"id":"https://openalex.org/C2777318727","wikidata":"https://www.wikidata.org/wiki/Q409464","display_name":"Lactate dehydrogenase","level":3,"score":0.49066340923309326},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4893264174461365},{"id":"https://openalex.org/C2780261098","wikidata":"https://www.wikidata.org/wiki/Q412486","display_name":"Allopurinol","level":2,"score":0.47224920988082886},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.437274307012558},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.34243452548980713},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.21263855695724487},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16993388533592224},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.09232395887374878},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.08551380038261414}],"mesh":[{"descriptor_ui":"D000046","descriptor_name":"Academic Medical Centers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002118","descriptor_name":"Calcium","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003404","descriptor_name":"Creatinine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006074","descriptor_name":"Gout Suppressants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006074","descriptor_name":"Gout Suppressants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006863","descriptor_name":"Hydrogen-Ion Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007770","descriptor_name":"L-Lactate Dehydrogenase","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010758","descriptor_name":"Phosphorus","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014503","descriptor_name":"Urate Oxidase","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014503","descriptor_name":"Urate Oxidase","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014527","descriptor_name":"Uric Acid","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D015275","descriptor_name":"Tumor Lysis Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015275","descriptor_name":"Tumor Lysis Syndrome","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D015275","descriptor_name":"Tumor Lysis Syndrome","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D015992","descriptor_name":"Body Mass Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D033461","descriptor_name":"Hyperuricemia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/1078155218791333","doi":"https://doi.org/10.1177/1078155218791333","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1078155218791333","pdf_url":null,"source":{"id":"https://openalex.org/S66425452","display_name":"Journal of Oncology Pharmacy Practice","issn_l":"1078-1552","issn":["1078-1552","1477-092X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Oncology Pharmacy Practice","raw_type":"journal-article"},{"id":"pmid:30111244","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30111244","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1562139111","https://openalex.org/W1740327132","https://openalex.org/W1966245964","https://openalex.org/W1968008584","https://openalex.org/W1994593880","https://openalex.org/W2001133874","https://openalex.org/W2012950388","https://openalex.org/W2025911882","https://openalex.org/W2036177444","https://openalex.org/W2039383497","https://openalex.org/W2050994521","https://openalex.org/W2072270671","https://openalex.org/W2090573786","https://openalex.org/W2095026923","https://openalex.org/W2095998688","https://openalex.org/W2097084508","https://openalex.org/W2098684703","https://openalex.org/W2110802171","https://openalex.org/W2114126778","https://openalex.org/W2122479144","https://openalex.org/W2141234027","https://openalex.org/W2142724532","https://openalex.org/W2149569497","https://openalex.org/W2155237074","https://openalex.org/W2162403132","https://openalex.org/W2167545521","https://openalex.org/W2339246966","https://openalex.org/W2344822151","https://openalex.org/W2494299944","https://openalex.org/W2554310457"],"related_works":["https://openalex.org/W2001895853","https://openalex.org/W3176645822","https://openalex.org/W3197532559","https://openalex.org/W2339246966","https://openalex.org/W2019077795","https://openalex.org/W2114126778","https://openalex.org/W2533496686","https://openalex.org/W2050994521","https://openalex.org/W2028024825","https://openalex.org/W4405393339"],"abstract_inverted_index":{"BACKGROUND:":[0],"Tumor":[1],"lysis":[2,47,100,310],"syndrome":[3],"is":[4],"an":[5],"oncologic":[6,154],"emergency":[7],"due":[8],"to":[9,17,39,51,115,140,273,307],"the":[10,53,96,169,196,274],"release":[11],"of":[12,37,55,59,93,98,121,187,190,287,294,302],"tumor":[13,46,99,309],"cell":[14],"contents,":[15],"leading":[16],"metabolic":[18],"derangements.":[19],"Rasburicase,":[20],"a":[21,33,79,89,290,298],"recombinant":[22],"urate":[23],"oxidase,":[24],"catabolizes":[25],"uric":[26,81,108,132,212,262,281],"acid.":[27],"At":[28],"our":[29,279],"institution,":[30],"we":[31],"administer":[32],"single":[34,56,90,291,299],"6-mg":[35,57,91,292,300],"dose":[36,58,92,189,293,301],"rasburicase":[38,60,67,94,122,141,191,276,295,303],"patients":[40,76,268,288],"who":[41,77,269],"are":[42],"at":[43],"risk":[44,63],"for":[45,95,312],"syndrome.":[48,101],"We":[49,70],"aimed":[50],"assess":[52],"efficacy":[54],"and":[61,87,153,232,239,249],"explore":[62],"factors":[64],"associated":[65],"with":[66,144],"failure.":[68],"METHODS:":[69],"report":[71],"results":[72],"in":[73,142,216,267,285],"92":[74],"adult":[75],"had":[78],"baseline":[80,211,261],"acid":[82,109,133,213,263,282],"greater":[83],"than":[84,112,218],"7.5":[85,116],"mg/dL":[86,117,221,242],"received":[88],"management":[97],"Responders":[102],"were":[103,166,192,235,265],"defined":[104],"as":[105],"those":[106],"whose":[107],"was":[110,128,214],"less":[111],"or":[113],"equal":[114],"within":[118,184],"24-36":[119],"h":[120,186],"administration.":[123],"The":[124],"primary":[125],"end":[126,136],"point":[127],"response":[129,139],"based":[130],"on":[131],"level.":[134],"Secondary":[135],"points":[137],"included":[138],"association":[143],"lactate":[145,163],"dehydrogenase,":[146],"serum":[147,230],"creatinine,":[148],"calcium,":[149],"phosphorus,":[150],"blood":[151],"pH,":[152],"diagnosis.":[155],"RESULTS:":[156],",":[157],"respectively,":[158,176,205,225],"p":[159,177,206,226,246,255],"=":[160,178,200,207,227,247,256],"0.6.":[161],"Baseline":[162,229],"dehydrogenase":[164],"levels":[165,264,283],"similar":[167,194,236],"between":[168,195,237],"groups:":[170],"756":[171],"U/L":[172],"vs.":[173,203,222,243,252],"892":[174],"U/L,":[175],"0.33.":[179],"Blood":[180],"pH":[181],"values":[182],"documented":[183],"24":[185],"first":[188,275],"also":[193],"two":[197],"groups":[198],"(n":[199],"30;":[201],"7.33":[202],"7.34":[204],"0.6).":[208],"However,":[209],"median":[210],"lower":[215],"responders":[217,238],"non-responders:":[219],"12.3":[220],"17.3":[223],"mg/dL,":[224],"0.012.":[228],"creatinine":[231,233],"clearance":[234],"non-responders":[240],"(2.2":[241],"3.95":[244],"mg/dL;":[245],"0.12":[248],"29":[250],"mL/min":[251],"16":[253],"mL/min;":[254],"0.11,":[257],"respectively).":[258],"CONCLUSIONS:":[259],"Higher":[260],"observed":[266],"did":[270],"not":[271],"respond":[272],"dose.":[277],"In":[278],"study,":[280],"normalized":[284],"95%":[286],"after":[289],"indicating":[296],"that":[297],"may":[304],"be":[305],"sufficient":[306],"manage":[308],"syndrome,":[311],"most":[313],"patients.":[314]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-08-22T00:00:00"}